Results for tag: "Nifekalant"

Nifekalant is a class of cardiovascular drugs used to treat arrhythmias, or abnormal heart rhythms. It works by blocking the sodium channels in the heart, which helps to regulate the heart rate. Nifekalant is used to treat atrial fibrillation, atrial flutter, and ventricular tachycardia. It is also used to prevent recurrence of atrial fibrillation after cardioversion. Nifekalant is available in both oral and intravenous forms. Nifekalant is a widely used drug in the cardiovascular market, and is used in many countries around the world. It is generally well tolerated, with few side effects. Common side effects include dizziness, headache, nausea, and fatigue. The nifekalant market is highly competitive, with many companies offering their own versions of the drug. Some of the major players in the market include AstraZeneca, Pfizer, Sanofi, and Novartis. Other companies include Daiichi Sankyo, Merck, and GlaxoSmithKline. Show Less Read more